Procalcitonin Is Not a Reliable Biomarker of Bacterial Coinfection in People With Coronavirus Disease 2019 Undergoing Microbiological Investigation at the Time of Hospital Admission

ISARIC4C Investigators, Katharine A Relph, Clark D Russell, Cameron J Fairfield, Lance Turtle, Thushan De Silva, Matthew K Siggins, Thomas M Drake, Ryan S Thwaites, Simon Abrams, Shona C Moore, Hayley E Hardwick, Wilna Oosthuyzen, Ewen M Harrison, Annemarie B Docherty, Peter J M Openshaw, J Kenneth Baillie, Malcolm G Semple, Antonia Ho

Research output: Contribution to journalArticlepeer-review

Abstract / Description of output

Admission procalcitonin measurements and microbiology results were available for 1040 hospitalized adults with coronavirus disease 2019 (from 48 902 included in the International Severe Acute Respiratory and Emerging Infections Consortium World Health Organization Clinical Characterisation Protocol UK study). Although procalcitonin was higher in bacterial coinfection, this was neither clinically significant (median [IQR], 0.33 [0.11–1.70] ng/mL vs 0.24 [0.10–0.90] ng/mL) nor diagnostically useful (area under the receiver operating characteristic curve, 0.56 [95% confidence interval, .51–.60]).
Original languageEnglish
JournalOpen forum infectious diseases
Volume9
Issue number5
DOIs
Publication statusPublished - 1 May 2022

Fingerprint

Dive into the research topics of 'Procalcitonin Is Not a Reliable Biomarker of Bacterial Coinfection in People With Coronavirus Disease 2019 Undergoing Microbiological Investigation at the Time of Hospital Admission'. Together they form a unique fingerprint.

Cite this